secwatch / observer
8-K filed June 22, 2023, 7:59 PM ET ticker AHCO CIK 0001725255
other confidence high sentiment neutral materiality 0.15

AdaptHealth shareholders elect directors, ratify KPMG, approve say-on-pay

AdaptHealth Corp.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

AdaptHealth Corp. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-21 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-21
Exact text from the filing
2. Ratification of Appointment of Independent Registered Public Accounting Firm. For Against Abstain 97,283,371 553,816 13,721
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

AdaptHealth Corp. shareholders approved Non-binding advisory vote to approve the compensation paid to the Company's named executive officers at the 2023-06-21 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-06-21
Exact text from the filing
3. Non-binding advisory vote to approve the compensation paid to the Company's named executive officers. For Against Abstain Broker Non-Vote 82,245,888 989,731 17,221 14,598,068
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

AdaptHealth Corp. shareholders approved Election of Class I Directors at the 2023-06-21 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-21
Exact text from the filing
1. Election of Class I Directors. Name For Withheld Broker Non-Vote Richard Barasch 49,170,889 34,081,951 14,598,068 Gregory Belinfanti 75,439,182 7,813,658 14,598,068
View on SEC.gov

211 shareholder votes filed in the last 30 days. Browse all shareholder votes →

AdaptHealth Corp. filing history →

Source: SEC EDGAR
accession 0001104659-23-073756
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.